Aspire Biopharma Holdings, Inc. - Common Stock, par value $0.0001 per share (ASBP)

CUSIP: 738920107

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
5,250,000
Total 13F shares
1,435,984
Share change
+1,435,984
Total reported value
$875,750
Price per share
$0.58
Number of holders
15
Value change
+$875,750
Number of buys
15

Security key

738920107

Report period

Q1 2025

Institutions

15

Top holders

10

Ownership snapshot

Top shareholders of ASBP - Aspire Biopharma Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Harraden Circle Investmen...
13D/G signal
Harraden Circle Investmen...
Evidence rows
3
Latest as of
31 Mar 2025
13D/G 3/4/5 Lead comparable stake: 0.31% 13D/G row: Harraden Circle Investments, LLC
Holder Evidence Ownership % Position 12M Net Δ As of
Harraden Circle Investments, LLC
13D/G
0.31%
$70,500
150,000 shares
$0 31 Mar 2025
Surendra K. Ajjarapu
3/4/5
Chief Executive Officer, Director, 10%+ Owner
class O/S missing
4,317,500 shares
18 Aug 2023
PowerUp Sponsor LLC
3/4/5
10%+ Owner
class O/S missing
2,870,000 shares
18 Aug 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
1,435,984
Rows loaded
15
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q1 2025 vs Q4 2025 Across Filers

Q4 2025 holders
30
Q1 2025 holders
15
Holder diff
-15
Investor Q4 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .